[Recognizing the "neck-tongue" syndrome].
Nicolas
X
X
Vaillant
P-Y
PY
Bellard
S
S
D000085:Acetates / Q000627:therapeutic use; D000588:Amines; D000700:Analgesics / Q000627:therapeutic use; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D001168:Arthritis / Q000150:complications; D002574:Cervical Vertebrae; D003509:Cyclohexanecarboxylic Acids; D003937:Diagnosis, Differential; D005260:Female; D000077206:Gabapentin; D006801:Humans; D006987:Hypesthesia / Q000175:diagnosis*; D007002:Hypoglossal Nerve / Q000502:physiology; D007052:Ibuprofen / Q000627:therapeutic use; D008036:Lingual Nerve / Q000502:physiology; D008875:Middle Aged; D019547:Neck Pain / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D010146:Pain / Q000175:diagnosis / Q000209:etiology*; D013122:Spinal Diseases / Q000150:complications; D013577:Syndrome; D014059:Tongue / Q000294:innervation*; D014060:Tongue Diseases / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D007052:Ibuprofen